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Background: Inflammation plays a key role in the development of atherosclerosis leading to manifest cardiovascular disease. YKL-40 is a 
glycoprotein secreted by macrophages and neutrophils in tissues with inflammation. Plasma YKL-40 is increased in patients with acute and chronic 
coronary artery disease (CAD) and associated with cardiovascular and all-cause mortality in patients with stable CAD. Furthermore, plasma YKL-40 
seems to be related to 1, 2 and 3 coronary vessel disease in patients with stable angina pectoris. The aim was to further explore the correlation 
between YKL-40, High Sensitivity C-Reactive Protein (HsCRP) and different methods for assessments of CAD degree on angiographies.
Methods: Plasma YKL-40 and HsCRP levels were determined in samples from 206 consecutive patients with stable angina pectoris admitted for 
elective coronary angiography (CAG). Plasma YKL-40 in 245 healthy subjects was used for comparison. In addition to one to three vessel stenosis 
scores, two new scores for evaluating coronary angiographies were invented for discriminating between focal and diffuse CAD and the extent of 
myocardial ischemia.
Results: Plasma YKL-40 levels were increased (p<0.001) in patients with CAD compared to healthy controls. Univariate analyses demonstrated that 
plasma YKL-40 was significantly associated with ischemic myocardium score, age, hypertension, peripheral vascular disease and serum creatinine 
levels. HsCRP was associated with hypertension, body mass index and smoking habits. Multivariate analyses showed that YKL-40 was related to 
HsCRP, peripheral artery disease, hypertension, and statin treatment; and HsCRP was related to chronic obstructive pulmonary disease, and body 
mass index, and smoking habits.
Conclusions: Plasma YKL-40 was increased in patients with CAD compared to controls. The ischemic myocardium score was related to YKL-40 
in univariate analyses, but not in multivariate analyses. There was no relation between YKL-40 and HsCRP levels and degree of CAD using several 
different scoring systems for extend of CAD.
